131 results on '"Iaria, M."'
Search Results
2. Long-terms Outcomes of Open and Laparoscopic Liver Resection of the Posterorosuperior Segments: The Evolution through the Years of a Single Surgeon Experience
- Author
-
Giuffrida, M., primary, Iaria, M., additional, Valle, R. Dalla, additional, and Valle, B. Dalla, additional
- Published
- 2023
- Full Text
- View/download PDF
3. The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study
- Author
-
Famularo, S., Donadon, M., Cipriani, F., Ardito, F., Iaria, M., Carissimi, F., Perri, P., Dominioni, T., Zanello, M., Conci, S., Molfino, S., D'Acapito, F., Germani, P., Ferrari, C., Patauner, S., Pinotti, E., Sciannamea, I., Garatti, M., Lodo, E., Troci, A., Delvecchio, A., Floridi, A., Bernasconi, D. P., Fumagalli, L., Chiarelli, M., Memeo, R., Crespi, M., Zanus, G., Zimmitti, G., Antonucci, A., Zago, M., Frena, A., Griseri, G., Tarchi, P., Ercolani, G., Baiocchi, G. L., Ruzzenente, A., Jovine, E., Maestri, M., Grazi, G. L., Valle, R. D., Giuliante, F., Aldrighetti, L., Romano, F., Torzilli, G., Costa, G., Ciulli, C., Giani, A., Ratti, F., Bellobono, M., Cremaschi, E., Valsecchi, M. G., De Peppo, V., Calabrese, F., Desario, G., Lazzari, G., Cucchetti, A., Cosola, D., Percivale, A., Ciola, M., Montuori, M., Frassani, S., Manzoni, A., Salvador, L., Pennacchi, L., Corleone, P., Conticchio, M., Famularo, S., Donadon, M., Cipriani, F., Ardito, F., Iaria, M., Carissimi, F., Perri, P., Dominioni, T., Zanello, M., Conci, S., Molfino, S., D'Acapito, F., Germani, P., Ferrari, C., Patauner, S., Pinotti, E., Sciannamea, I., Garatti, M., Lodo, E., Troci, A., Delvecchio, A., Floridi, A., Bernasconi, D. P., Fumagalli, L., Chiarelli, M., Memeo, R., Crespi, M., Zanus, G., Zimmitti, G., Antonucci, A., Zago, M., Frena, A., Griseri, G., Tarchi, P., Ercolani, G., Baiocchi, G. L., Ruzzenente, A., Jovine, E., Maestri, M., Grazi, G. L., Valle, R. D., Giuliante, F., Aldrighetti, L., Romano, F., Torzilli, G., Costa, G., Ciulli, C., Giani, A., Ratti, F., Bellobono, M., Cremaschi, E., Valsecchi, M. G., De Peppo, V., Calabrese, F., Desario, G., Lazzari, G., Cucchetti, A., Cosola, D., Percivale, A., Ciola, M., Montuori, M., Frassani, S., Manzoni, A., Salvador, L., Pennacchi, L., Corleone, P., Conticchio, M., Famularo S., Donadon M., Cipriani F., Ardito F., Iaria M., Carissimi F., Perri P., Dominioni T., Zanello M., Conci S., Molfino S., D'Acapito F., Germani P., Ferrari C., Patauner S., Pinotti E., Sciannamea I., Garatti M., Lodo E., Troci A., Delvecchio A., Floridi A., Bernasconi D.P., Fumagalli L., Chiarelli M., Memeo R., Crespi M., Zanus G., Zimmitti G., Antonucci A., Zago M., Frena A., Griseri G., Tarchi P., Ercolani G., Baiocchi G.L., Ruzzenente A., Jovine E., Maestri M., Grazi G.L., Valle R.D., Giuliante F., Aldrighetti L., Romano F., Torzilli G., Costa G., Ciulli C., Giani A., Ratti F., Bellobono M., Cremaschi E., Valsecchi M.G., De Peppo V., Calabrese F., DeSario G., Lazzari G., Cucchetti A., Cosola D., Percivale A., Ciola M., Montuori M., Frassani S., Manzoni A., Salvador L., Pennacchi L., Corleone P., Conticchio M., Famularo, S, Donadon, M, Cipriani, F, Ardito, F, Iaria, M, Carissimi, F, Perri, P, Dominioni, T, Zanello, M, Conci, S, Molfino, S, D'Acapito, F, Germani, P, Ferrari, C, Patauner, S, Pinotti, E, Sciannamea, I, Garatti, M, Lodo, E, Troci, A, Delvecchio, A, Floridi, A, Bernasconi, D, Fumagalli, L, Chiarelli, M, Memeo, R, Crespi, M, Zanus, G, Zimmitti, G, Antonucci, A, Zago, M, Frena, A, Griseri, G, Tarchi, P, Ercolani, G, Baiocchi, G, Ruzzenente, A, Jovine, E, Maestri, M, Grazi, G, Valle, R, Giuliante, F, Aldrighetti, L, Romano, F, Torzilli, G, Costa, G, Ciulli, C, Giani, A, Ratti, F, Bellobono, M, Cremaschi, E, Valsecchi, M, De Peppo, V, Calabrese, F, Desario, G, Lazzari, G, Cucchetti, A, Cosola, D, Percivale, A, Ciola, M, Montuori, M, Frassani, S, Manzoni, A, Salvador, L, Pennacchi, L, Corleone, P, and Conticchio, M
- Subjects
Laparoscopic surgery ,medicine.medical_specialty ,endocrine system ,Carcinoma, Hepatocellular ,Disease-free survival ,Hepatocellular carcinoma ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,030230 surgery ,NO ,Liver surgery ,Overall survival ,Postoperative ascites ,Postoperative complications ,03 medical and health sciences ,0302 clinical medicine ,Retrospective Studie ,Ascites ,Risk of mortality ,Medicine ,Hepatectomy ,Humans ,Survival analysis ,LS7_4 ,Retrospective Studies ,business.industry ,Proportional hazards model ,Carcinoma ,Liver Neoplasms ,Gastroenterology ,Hepatocellular ,medicine.disease ,Surgery ,Postoperative complication ,Postoperative ascite ,Neoplasm Recurrence ,Local ,030220 oncology & carcinogenesis ,Ascite ,medicine.symptom ,Neoplasm Recurrence, Local ,business ,Complication ,Varices ,Human - Abstract
Background: Postoperative ascites (POA) is the most common complication after liver surgery for hepatocarcinoma (HCC), but its impact on survival is not reported. The aim of the study is to investigate its impact on overall survival (OS) and disease-free survival (DFS), and secondarily to identify the factors that may predict the occurrence. Method: Data were collected from 23 centers participating in the Italian Surgical HCC Register (HE.RC.O.LE.S. Group) between 2008 and 2018. POA was defined as ≥500 ml of ascites in the drainage after surgery. Survival analysis was conducted by the Kaplan Meier method. Risk adjustment analysis was conducted by Cox regression to investigate the risk factors for mortality and recurrence. Results: Among 2144 patients resected for HCC, 1871(88.5%) patients did not experience POA while 243(11.5%) had the complication. Median OS for NO-POA group was not reached, while it was 50 months (95%CI = 41–71) for those with POA (p < 0.001). POA independently increased the risk of mortality (HR = 1.696, 95%CI = 1.352–2.129, p < 0.001). Relapse risk after surgery was not predicted by the occurrence of POA. Presence of varices (OR = 2.562, 95%CI = 0.921–1.822, p < 0.001) and bilobar disease (OR = 1.940, 95%CI = 0.921–1.822, p: 0.004) were predictors of POA, while laparoscopic surgery was protective (OR = 0.445, 95%CI = 0.295–0.668, p < 0.001). Ninety-day mortality was higher in the POA group (9.1% vs 1.9% in NO-POA group, p < 0.001). Conclusion: The occurrence of POA after surgery for HCC strongly increases the risk of long-term mortality and its occurrence is relatively frequent. More efforts in surgical planning should be made to limit its occurrence.
- Published
- 2021
4. The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis
- Author
-
Serenari, M., Lenzi, J., Cucchetti, A., Cipriani, F., Donadon, M., Ardito, Francesco, Fazio, F., Nicolini, D., Iaria, M., Famularo, S., Perri, P., Ansaloni, L., Zanello, M., Lai, Q., Conci, S., Molfino, S., Ferrari, C., Germani, P., Zago, M., Romano, M., Zimmitti, G., Antonucci, A., Fumagalli, L., Troci, A., Ferraro, V., Memeo, R., Crespi, M., Chiarelli, M., Ercolani, G., Hilal, M. A., Zanus, G., Pinotti, E., Tarchi, P., Griseri, G., Baiocchi, G. L., Ruzzenente, A., Rossi, M., Jovine, E., Maestri, M., Grazi, G. L., Romano, F., Dalla Valle, R., Ravaioli, M., Vivarelli, M., Ferrero, A., Giuliante, Felice, Torzilli, G., Aldrighetti, L., Cescon, M., Gorgone, M., Ratti, F., Costa, G., Razionale, Francesco, Russolillo, N., Marinelli, Luca, Giuffrida, M., Scotti, M., Garancini, M., De Peppo, V., De Stefano, F., Laureiro, Z. L., Marchitelli, I., Franceschi, A., Cosola, D., Corleone, P., Montuori, M., Salvador, L., Manzoni, Annamaria, La Barba, G., Calcagno, P., Pennacchi, L., Conticchio, M., Serenari, Matteo, Lenzi, Jacopo, Cucchetti, Alessandro, Cipriani, Federica, Donadon, Matteo, Ardito, Francesco, Fazio, Federico, Nicolini, Daniele, Iaria, Maurizio, Famularo, Simone, Perri, Pasquale, Ansaloni, Luca, Zanello, Matteo, Lai, Quirino, Conci, Simone, Molfino, Sarah, Ferrari, Cecilia, Germani, Paola, Zago, Mauro, Romano, Maurizio, Zimmitti, Giuseppe, Antonucci, Adelmo, Fumagalli, Luca, Troci, Albert, Ferraro, Valentina, Memeo, Riccardo, Crespi, Michele, Chiarelli, Marco, Ercolani, Giorgio, Hilal, Mohamed Abu, Zanus, Giacomo, Pinotti, Enrico, Tarchi, Paola, Griseri, Guido, Baiocchi, Gian Luca, Ruzzenente, Andrea, Rossi, Massimo, Jovine, Elio, Maestri, Marcello, Grazi, Gian Luca, Romano, Fabrizio, Dalla Valle, Raffaele, Ravaioli, Matteo, Vivarelli, Marco, Ferrero, Alessandro, Giuliante, Felice, Torzilli, Guido, Aldrighetti, Luca, and Cescon, Matteo
- Subjects
hepatectomy ,complications ,liver transplantation ,salvage ,Settore MED/18 - CHIRURGIA GENERALE ,Surgery ,hepatocellular carcinoma ,case-mix - Abstract
To evaluate the effect of a liver transplantation (LT) program on the outcomes of resectable hepatocellular carcinoma (HCC).Surgical treatment of HCC includes both hepatic resection (HR) and LT. However, the presence of cirrhosis and the possibility of recurrence make the management of this disease complex and probably different according to the presence of a LT program.Patients undergoing HR for HCC between January 2005 and December 2019 were identified from a national database of HCC. The main study outcomes were major surgical complications according to the Comprehensive Complication Index (CCI), post-hepatectomy liver failure (PHLF), 90-day mortality, overall survival (OS), and disease-free survival (DFS). Secondary outcomes were salvage liver transplantation (SLT) and post-recurrence survival (PRS).A total of 3202 patients were included from 25 hospitals over the study period. Three out of 25 (12%) had a LT program. The presence of a LT program within a center was associated with a reduced probability of PHLF (OR=0.38) but not with OS and DFS. There was an increased probability of SLT when HR was performed in a transplant hospital (OR=12.05). Among transplant-eligible patients, those who underwent LT had a significantly longer PRS.This study showed that the presence of a LT program was associated with decreased PHLF rates and an increased probability to receive SLT in case of recurrence.
- Published
- 2022
5. Wide nervous section to prevent post-operative inguinodynia after prosthetic hernia repair: a single center experience
- Author
-
Zannoni, M., Nisi, P., Iaria, M., Luzietti, E., Sianesi, M., and Viani, L.
- Published
- 2015
- Full Text
- View/download PDF
6. The largest western experience on salvage hepatectomy for recurrent hepatocellular carcinoma: propensity score-matched analysis on behalf of He.RC.O.Le.Study Group
- Author
-
Iaria, M, Bianchi, G, Fazio, F, Ardito, F, Perri, P, Pontarolo, N, Conci, S, Donadon, M, Zanello, M, Lai, Q, Famularo, S, Molfino, S, Sciannamea, I, Fumagalli, L, Germani, P, Floridi, A, Ferrari, C, Zimmitti, G, Troci, A, Zago, M, Ferraro, V, Cipriani, F, Patauner, S, La Barba, G, Romano, M, Zanus, G, Ercolani, G, Frena, A, Aldrighetti, L, Memeo, R, Pinotti, E, Crespi, M, Hilal, Ma, Griseri, G, Tarchi, P, Chiarelli, M, Antonucci, A, Baiocchi, Gl, Romano, F, Rossi, M, Jovine, E, Torzilli, G, Ruzzenente, A, Maestri, M, Grazi, Gl, Giuliante, F, Ferrero, A, Dalla Valle, R, Group, HE. RC. O. LE. S., HERCOLES GROUP Contributors: Mario Giuffrida, Nadia, Russolillo, Francesco, Razionale, DE PEPPO, Valerio, Matteo, Tomasoni, Ivan, Marchitelli, Guido, Costa, LARGHI LAUREIRO, Zoe, Mauro, Scotti, Pietro, Calcagno, Davide, Cosola, Angelo, Franceschi, Alberto, Manzoni, Luca, Pennacchi, Mauro, Montuori, Maria, Conticchio, Francesca, Ratti, Francesca, Notte, Alessandro, Cucchetti, Luca, Salvador, Pio, Corleone, Mattia, Garancini, and Cristina, Ciulli.
- Subjects
long-term outcome ,recurrence ,Carcinoma, Hepatocellular ,Hepatology ,Liver resection ,Hepatocellular carcinoma ,Settore MED/18 - CHIRURGIA GENERALE ,Carcinoma ,Liver Neoplasms ,Gastroenterology ,Hepatocellular ,NO ,Neoplasm Recurrence ,Treatment Outcome ,Local ,Recurrent disease ,Hepatectomy ,Humans ,HCC ,Neoplasm Recurrence, Local ,Liver surgery ,Propensity Score ,Retrospective Studies - Abstract
We aimed to evaluate, in a large Western cohort, perioperative and long-term oncological outcomes of salvage hepatectomy (SH) for recurrent hepatocellular carcinoma (rHCC) after primary hepatectomy (PH) or locoregional treatments.Data were collected from the Hepatocarcinoma Recurrence on the Liver Study Group (He.RC.O.Le.S.) Italian Registry. After 1:1 propensity score-matched analysis (PSM), two groups were compared: the PH group (patients submitted to resection for a first HCC) and the SH group (patients resected for intrahepatic rHCC after previous HCC-related treatments).2689 patients were enrolled. PH included 2339 patients, SH 350. After PSM, 263 patients were selected in each group with major resected nodule median size, intraoperative blood loss and minimally invasive approach significantly lower in the SH group. Long-term outcomes were compared, with no difference in OS and DFS. Univariate and multivariate analyses revealed only microvascular invasion as an independent prognostic factor for OS.SH proved to be equivalent to PH in terms of safety, feasibility and long-term outcomes, consistent with data gathered from East Asia. In the awaiting of reliable treatment-allocating algorithms for rHCC, SH appears to be a suitable alternative in patients fit for surgery, regardless of the previous therapeutic modality implemented.
- Published
- 2021
7. Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience
- Author
-
Famularo, S., Donadon, M., Cipriani, Fabrizio, Ardito, Francesco, Carissimi, F., Perri, Pierluigi, Iaria, M., Dominioni, T., Zanello, M., Conci, S., Molfino, S., Labarba, G., Ferrari, C., Germani, P., Patauner, S., Pinotti, E., Lodo, E., Garatti, M., Sciannamea, I., Troci, A., Conticchio, M., Floridi, A., Chiarelli, M., Fumagalli, L., Memeo, R., Crespi, M., Antonucci, Anna Maria, Zimmitti, Giuseppe, Zanus, G., Zago, M., Frena, A., Tarchi, P., Griseri, G., Ercolani, G., Baiocchi, G. L., Ruzzenente, A., Jovine, E., Maestri, Marta, Dallavalle, R., Grazi, G. L., Giuliante, Felice, Aldrighetti, L., Torzilli, Guido, Romano, Federica, Bernasconi, D. P., Ciulli, C., Giani, A., Costa, G., Ratti, F., Bellobono, M., Calabrese, F., Cremaschi, E., De Peppo, V., Cucchetti, A., Lazzari, Giovanni, Percivale, A., Ciola, M., Sega, V., Frassani, S., Del Vecchio, Arianna, Pennacchi, L., Corleone, P., Cosola, D., Salvador, L., Montuori, M., Famularo, Simone, Donadon, Matteo, Cipriani, Federica, Ardito, Francesco, Carissimi, Francesca, Perri, Pasquale, Iaria, Maurizio, Dominioni, Tommaso, Zanello, Matteo, Conci, Simone, Molfino, Sarah, LaBarba, Giuliano, Ferrari, Cecilia, Germani, Paola, Patauner, Stefan, Pinotti, Enrico, Lodo, Enrico, Garatti, Marco, Sciannamea, Ivano, Troci, Albert, Conticchio, Maria, Floridi, Antonio, Chiarelli, Marco, Fumagalli, Luca, Memeo, Riccardo, Crespi, Michele, Antonucci, Adelmo, Zimmitti, Giuseppe, Zanus, Giacomo, Zago, Mauro, Frena, Antonio, Tarchi, Paola, Griseri, Guido, Ercolani, Giorgio, Baiocchi, Gian Luca, Ruzzenente, Andrea, Jovine, Elio, Maestri, Marcello, DallaValle, Raffaele, Grazi, Gian Luca, Giuliante, Felice, Aldrighetti, Luca, Torzilli, Guido, Romano, Fabrizio, Famularo, S., Donadon, M., Cipriani, F., Ardito, F., Carissimi, F., Perri, P., Iaria, M., Dominioni, T., Zanello, M., Conci, S., Molfino, S., Labarba, G., Ferrari, C., Germani, P., Patauner, S., Pinotti, E., Lodo, E., Garatti, M., Sciannamea, I., Troci, A., Conticchio, M., Floridi, A., Chiarelli, M., Fumagalli, L., Memeo, R., Crespi, M., Antonucci, A., Zimmitti, G., Zanus, G., Zago, M., Frena, A., Tarchi, P., Griseri, G., Ercolani, G., Baiocchi, G. L., Ruzzenente, A., Jovine, E., Maestri, M., Dallavalle, R., Grazi, G. L., Giuliante, F., Aldrighetti, L., Torzilli, G., Romano, F., Bernasconi, D. P., Ciulli, C., Giani, A., Costa, G., Ratti, F., Bellobono, M., Calabrese, F., Cremaschi, E., De Peppo, V., Cucchetti, A., Lazzari, G., Percivale, A., Ciola, M., Sega, V., Frassani, S., Del Vecchio, A., Pennacchi, L., Corleone, P., Cosola, D., Salvador, L., and Montuori, M.
- Subjects
Male ,Cirrhosis ,Outcome Assessment ,Hepatocellular carcinoma ,Settore MED/18 - CHIRURGIA GENERALE ,Datasets as Topic ,HERCOLES ,Hepatocarcinoma recurrence ,Liver surgery ,Redo surgery ,Outcome Assessment, Health Care ,Ascites ,Registries ,Laparoscopy ,education.field_of_study ,medicine.diagnostic_test ,Liver Neoplasms ,Middle Aged ,Italy ,Local ,Radiological weapon ,Female ,medicine.symptom ,Reoperation ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Population ,NO ,Internal medicine ,medicine ,Hepatectomy ,Humans ,education ,LS7_4 ,Aged ,business.industry ,Carcinoma ,Hepatocellular ,Perioperative ,Hepatology ,medicine.disease ,Surgery ,Health Care ,Neoplasm Recurrence ,Neoplasm Recurrence, Local ,business - Abstract
Liver surgery is the first line treatment for hepatocarcinoma. Hepatocarcinoma Recurrence on the Liver Study (HERCOLES) Group was established in 2018 with the goal to create a network of Italian centres sharing data and promoting scientific research on hepatocellular carcinoma (HCC) in the surgical field. This is the first national report that analyses the trends in surgical and oncological outcomes. Register data were collected by 22 Italian centres between 2008 and 2018. One hundred sixty-four variables were collected, regarding liver functional status, tumour burden, radiological, intraoperative and perioperative data, histological features and oncological follow-up. 2381 Patients were enrolled. Median age was 70 (IQR 63-75) years old. Cirrhosis was present in 1491 patients (62.6%), and Child-A were 89.9% of cases. HCC was staged as BCLC0-A in almost 50% of cases, while BCLC B and C were 20.7% and 17.9% respectively. Major liver resections were 481 (20.2%), and laparoscopy was employed in 753 (31.6%) cases. Severe complications occurred only in 5%. Postoperative ascites was recorded in 10.5% of patients, while posthepatectomy liver failure was observed in 4.9%. Ninety-day mortality was 2.5%. At 5years, overall survival was 66.1% and disease-free survival was 40.9%. Recurrence was intrahepatic in 74.6% of cases. Redo-surgery and thermoablation for recurrence were performed up to 32% of cases. This is the most updated Italian report of the national experience in surgical treatment for HCC. This dataset is consistently allowing the participating centres in creating multicentric analysis which are already running with a very large sample size and strong power. Liver surgery is the first line treatment for hepatocarcinoma. Hepatocarcinoma Recurrence on the Liver Study (HERCOLES) Group was established in 2018 with the goal to create a network of Italian centres sharing data and promoting scientific research on hepatocellular carcinoma (HCC) in the surgical field. This is the first national report that analyses the trends in surgical and oncological outcomes. Register data were collected by 22 Italian centres between 2008 and 2018. One hundred sixty-four variables were collected, regarding liver functional status, tumour burden, radiological, intraoperative and perioperative data, histological features and oncological follow-up. 2381 Patients were enrolled. Median age was 70 (IQR 63–75) years old. Cirrhosis was present in 1491 patients (62.6%), and Child-A were 89.9% of cases. HCC was staged as BCLC0-A in almost 50% of cases, while BCLC B and C were 20.7% and 17.9% respectively. Major liver resections were 481 (20.2%), and laparoscopy was employed in 753 (31.6%) cases. Severe complications occurred only in 5%. Postoperative ascites was recorded in 10.5% of patients, while posthepatectomy liver failure was observed in 4.9%. Ninety-day mortality was 2.5%. At 5years, overall survival was 66.1% and disease-free survival was 40.9%. Recurrence was intrahepatic in 74.6% of cases. Redo-surgery and thermoablation for recurrence were performed up to 32% of cases. This is the most updated Italian report of the national experience in surgical treatment for HCC. This dataset is consistently allowing the participating centres in creating multicentric analysis which are already running with a very large sample size and strong power.
- Published
- 2020
8. The best potential treatment for recurrent hepatocellular carcinoma after surgery: a machine learning predictive model for treatment allocation based on an Italian multicentric database
- Author
-
Famularo, S., primary, Donadon, M., additional, Cipriani, F., additional, Fazio, F., additional, Ardito, F., additional, Carissimi, F., additional, Iaria, M., additional, Perri, P., additional, Conci, S., additional, Pontarolo, N., additional, Lai, Q., additional, La Barba, G., additional, Patauner, S., additional, Molfino, S., additional, Germani, P., additional, Manzoni, A., additional, Pinotti, E., additional, Zanello, M., additional, Fumagalli, L., additional, Ferrari, C., additional, Romano, M., additional, Delvecchio, A., additional, Bernasconi, D.P., additional, Valsecchi, M.G., additional, Antonucci, A., additional, Memeo, R., additional, Zanus, G., additional, Griseri, G., additional, Chiarelli, M., additional, Jovine, E., additional, Zago, M., additional, Zimmitti, G., additional, Tarchi, P., additional, Baiocchi, G.L., additional, Frena, A., additional, Ercolani, G., additional, Rossi, M., additional, Maestri, M., additional, Ruzzenente, A., additional, Grazi, G.L., additional, Valle, R. Dalla, additional, Romano, F., additional, Giuliante, F., additional, Ferrero, A., additional, Aldrighetti, L., additional, Torzilli, G., additional, and Group, HE.RC.O.LE.S., additional
- Published
- 2021
- Full Text
- View/download PDF
9. Fully laparoscopic pancreaticoduodenectomy with double purse-string pancreaticogastrostomy
- Author
-
Valle, R. Dalla, primary, Giuffrida, M., additional, Viani, L., additional, and Iaria, M., additional
- Published
- 2021
- Full Text
- View/download PDF
10. Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients
- Author
-
Iaria, M., Caccuri, F., Apostoli, P., Giagulli, C., Pelucchi, F., Padoan, R.F., Caruso, A., and Fiorentini, S.
- Published
- 2015
- Full Text
- View/download PDF
11. Epidemiology and outcome of multiple trauma in the elderly population in a tertiary care hospital in southern Italy
- Author
-
Gioffré-Florio M, Villari SA, Famá F, Surleti S, and Iaria M
- Subjects
Geriatrics ,RC952-954.6 - Published
- 2009
- Full Text
- View/download PDF
12. Secondary hemophagocytic lymphohistiocytosis: forget me not!
- Author
-
David, A., Iaria, C., Giordano, S., Iaria, M., and Cascio, A.
- Published
- 2012
- Full Text
- View/download PDF
13. The role of postoperative ascites In determining long term survival after curative surgery for hepatocarcinoma: a national multicentric study
- Author
-
Famularo, S., primary, Donadon, M., additional, Cipriani, F., additional, Ardito, F., additional, Carissimi, F., additional, Perri, P., additional, Iaria, M., additional, Conci, S., additional, Dominioni, T., additional, Zanello, M., additional, Molfino, S., additional, La Barba, G., additional, Ferrari, C., additional, Patauner, S., additional, Garatti, M., additional, Sciannamea, I., additional, Lodo, E., additional, Troci, A., additional, Del Vecchio, A., additional, Floridi, A., additional, Memeo, R., additional, Crespi, M., additional, Zanus, G., additional, Antonucci, A., additional, Zimmitti, G., additional, Frena, A., additional, Griseri, G., additional, Ercolani, G., additional, Baiocchi, GL., additional, Jovine, E., additional, Maestri, M., additional, Ruzzenente, A., additional, Valle, R. Dalla, additional, Grazi, GL., additional, Giuliante, F., additional, Aldrighetti, L., additional, Torzilli, G., additional, and Romano, F., additional
- Published
- 2020
- Full Text
- View/download PDF
14. Care or palliation for recurrent hepatocarcinoma: a multicentric national analysis of survival
- Author
-
Famularo, S., primary, Donadon, M., additional, Cipriani, F., additional, Ardito, F., additional, Maestri, M., additional, Dominioni, T., additional, Bernasconi, D.P., additional, Carissimi, F., additional, Iaria, M., additional, Cosimelli, M., additional, LaBarba, G., additional, Molfino, S., additional, Conci, S., additional, Ferrari, C., additional, Patauner, S., additional, Floridi, A., additional, Garatti, M., additional, Antonucci, A., additional, Del Vecchio, A., additional, Chiarelli, M., additional, Fumagalli, L., additional, Troci, A., additional, Percivale, A., additional, De Angelis, M., additional, Lodo, E., additional, Zanello, M., additional, Boccia, L., additional, Crespi, M., additional, Memeo, R., additional, Zanus, G., additional, Zimmitti, G., additional, Frena, A., additional, Griseri, G., additional, Ruzzenente, A., additional, Baiocchi, G.L., additional, Ercolani, G., additional, Grazi, G.L., additional, DallaValle, R., additional, Jovine, E., additional, Giuliante, F., additional, Aldrighetti, L., additional, Torzilli, G., additional, and Romano, F., additional
- Published
- 2020
- Full Text
- View/download PDF
15. Survival after the diagnosis of de novo malignancy in liver transplant recipients
- Author
-
Taborelli, M, Piselli, P, Ettorre, Gm, Baccarani, U, Burra, P, Lauro, A, Galatioto, L, Rendina, M, Shalaby, S, Petrara, R, Nudo, F, Toti, L, Fantola, G, Cimaglia, C, Agresta, A, Vennarecci, G, Pinna, Ad, Gruttadauria, S, Risaliti, A, Di Leo, A, Rossi, M, Tisone, G, Zamboni, F, Serraino, D, Zanus, G, Zanini, S, Rigotti, P, Schena, Fp, Grandaliano, G, Fiorentino, M, Di Gioia, P, Pellegrini, S, Zanfi, C, Scolari, Mp, Stefoni, S, Todeschini, P, Panicali, L, Valentini, C, Adani, Gl, Lorenzin, D, Colasanti, M, Coco, M, Ettorre, F, Santoro, R, Miglioresi, L, Mennini, G, Casella, A, Fazzolari, L, Sforza, D, Iaria, G, Gazia, C, Belardi, C, D'Offizi, G, Comandini, Uv, Lionetti, R, Montalbano, M, Taibi, C, Piredda, Gb, Michittu, Mb, Murgia, Mg, Onano, B, Fratino, L, Maso, Ld, De Paoli, P, Verdirosi, D, Vaccher, E, Pisani, F, Famulari, A, Delreno, F, Iesari, S, De Luca, L, Iaria, M, Capocasale, E, Cremaschi, E, Sandrini, S, Valerio, F, Mazzucotelli, V, Bossini, N, Setti, G, Veroux, M, Veroux, P, Giuffrida, G, Giaquinta, A, Zerbo, D, Busnach, G, Di Leo, L, Perrino, Ml, Querques, M, Colombo, V, Sghirlanzoni, Mc, Messa, P, Leoni, A, Sparacino, V, Caputo, F, Buscemi, B, Citterio, F, Spagnoletti, G, Salerno, Mp, Favi, E, Segoloni, Gp, Biancone, L, Lavacca, A, Maresca, Mc, Cascone, C, Virgilio, B, Donati, D, Dossi, F, Fontanella, A, Ambrosini, A, and Di Cicco, M.
- Published
- 2019
16. Laparoscopic spleen-preserving “tail-only” pancreatectomy for a left-sided neuroendocrine tumor
- Author
-
Dalla Valle, R., primary, Pellegrino, C., additional, and Iaria, M., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Radiofrequency-assisted liver partition for staged hepatectomy (R-ALPPS). A preliminary experience with a fully laparoscopic first stage approach
- Author
-
Iaria, M., primary, Rossini, M., additional, Pellegrino, C., additional, Lamecchi, L., additional, and Valle, R. Dalla, additional
- Published
- 2019
- Full Text
- View/download PDF
18. Risk‐adjusted benchmarks in laparoscopic liver surgery in a national cohort.
- Author
-
Russolillo, N., Aldrighetti, L., Cillo, U., Guglielmi, A., Ettorre, G. M., Giuliante, F., Mazzaferro, V., Dalla Valle, R., De Carlis, L., Jovine, E., Ferrero, A., Ratti, F., Lo Tesoriere, R., Gringeri, E., Ruzzenente, A., Levi Sandri, G. B., Ardito, F., Virdis, M., Iaria, M., and Ferla, F.
- Subjects
LAPAROSCOPIC surgery ,MINIMALLY invasive procedures ,LIVER surgery ,COMORBIDITY ,ODDS ratio - Abstract
Copyright of British Journal of Surgery is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2020
- Full Text
- View/download PDF
19. Salvage hepatectomy for HCC recurrence after failed RFA, TACE or PEI: an unlock gateway to think of
- Author
-
Petracca, G., primary, Iaria, M., additional, Ferrara, L., additional, Spotti, A., additional, Bianchi, G., additional, Missale, G., additional, and Dalla Valle, R., additional
- Published
- 2018
- Full Text
- View/download PDF
20. Surgical overview on kidney and pancreas transplantation [Problemi chirurgici nel trapianto di rene e di pancreas - Position paper]
- Author
-
Capocasale, and Berardinelli, E., and Beretta, L., and Berloco, C., and Boggi, P., and Boschiero, U., and Bretto, L., and Carmellini, P., Citterio, Franco, And, Concone, and De Carlis, G., and De Rosa, L., and Del Gaudio, P., and Di Sandro, M., and Di Tonno, S., and Faenza, P., and Famulari, A., and Giacomoni, A., and Giovannoni, A., and Iaria, M., and Lauterio, M., and Lasaponara, A., and Mazzoni, F., and Nicita, M. P., and Orsenigo, G., and Parolini, E., and Pietrabissa, D. C., and Pinna, A., and Pisani, A. D., and Ravaioli, F., and Rigotti, M., Romagnoli, Paolo, and Rossetti, J., and Secchi, O., and Socci, A., and and Vistoli, C.
- Subjects
SURGERY ,Settore MED/18 - CHIRURGIA GENERALE - Published
- 2016
21. Problemi chirurgici nel trapianto di rene e di pancreas - Position paper [Surgical overview on kidney and pancreas transplantation]
- Author
-
Capocasale, E., Berardinelli, L., Beretta, C., Berloco, P., Boggi, U., Boschiero, L., Bretto, P., Carmellini, M., Citterio, F., Concone, G., De Carlis, L., De Rosa, P., Del Gaudio, M., Di Sandro, S., Di Tonno, P., Faenza, A., Famulari, A., Giacomoni, A., Giovannoni, M., Iaria, M., Lauterio, A., Lasaponara, F., Mazzoni, M. P., Nicita, G., Orsenigo, E., Parolini, D. C., Pietrabissa, A., Pinna, A. D., Pisani, F., Ravaioli, M., Rigotti, P., Romagnoli, J., Rossetti, O., Secchi, A., Socci, C., and Vistoli, F.
- Subjects
failed allograft, kidney and pancreas transplantation, kidney preservation, living donation, recipient selection ,failed allograft ,living donation ,kidney and pancreas transplantation ,recipient selection ,kidney preservation - Published
- 2016
22. Incidental gallbladder carcinoma. Is poor prognosis related to late age of presentation?
- Author
-
Dalla Valle, R., primary, Lamecchi, L., additional, Perrone, G., additional, Pellegrino, C., additional, and Iaria, M., additional
- Published
- 2016
- Full Text
- View/download PDF
23. Managing a soft pancreatic stump with end-to-side interrupted double-layer pancreaticogastrostomy: How we do it!
- Author
-
Perrone, G., primary, Iaria, M., additional, Lamecchi, L., additional, Bonati, E., additional, and Dalla Valle, R., additional
- Published
- 2016
- Full Text
- View/download PDF
24. Early identification of patients at increased risk of liver failure, postoperative complications and death after major hepatectomy
- Author
-
Bonati, E., primary, Francesco, T., additional, Pedrazzi, G., additional, Iaria, M., additional, and Dalla Valle, R., additional
- Published
- 2016
- Full Text
- View/download PDF
25. Laparoscopic versus open liver resection for HCC: Preliminary case-matched analysis
- Author
-
Dalla Valle, R., primary, Perrone, G., additional, Bertocchi, E., additional, Bonati, E., additional, Montali, F., additional, and Iaria, M., additional
- Published
- 2016
- Full Text
- View/download PDF
26. Sintomi depressivi e disabilità in soggetti anziani ospedallizzati affetti da scompenso cardiaco
- Author
-
Cucinotta, M. D., Parisi, P., Mazza, M., Reitano, F., Femia, R., Iaria, M., Cama, G., and Basile, Giorgio
- Published
- 2010
27. Surgical Site and Early Urinary Tract Infections in 1000 Kidney Transplants With Antimicrobial Perioperative Prophylaxis
- Author
-
Capocasale, E., primary, De Vecchi, E., additional, Mazzoni, M.P., additional, Dalla Valle, R., additional, Pellegrino, C., additional, Ferretti, S., additional, Sianesi, M., additional, and Iaria, M., additional
- Published
- 2014
- Full Text
- View/download PDF
28. Ascite chilosa dopo nefrectomia laparoscopica nel donatore vivente
- Author
-
Iaria, M, Capocasale, E, Mazzoni, Mp, Dalla Valle, R, Gioffre', Maria, and Sianesi, M.
- Published
- 2009
29. Epidemiologia ed outcome del politrauma nella popolazione anziana in un centro ospedaliero di terzo livello dell'Italia Meridionale
- Author
-
Iaria, M, Surleti, Salvatore, Fama', Fausto, Villari, SANTA ALESSANDRA, and Gioffre', Maria
- Published
- 2008
30. Possibili effetti di un terremoto ignoto ai cataloghi su una villa romana imperiale in Alta val d'Agri
- Author
-
Russo, A, Mucciarelli, D, Liberatore, Domenico, Iaria, M, Gargano, Mp, and Bianca, M.
- Published
- 2007
31. Dalla villa dei Bruttii Praesentes alla proprietà imperiale. Il complesso archeologico di Marsicovetere - Barricelle (PZ)
- Author
-
Russo, A, Gargano, M. P., DI GIUSEPPE, H, Mucciarelli, M, Bianca, M, Liberatore, Domenico, and Iaria, M.
- Published
- 2007
32. Wide nervous section to prevent post-operative inguinodynia after prosthetic hernia repair: a single center experience
- Author
-
Zannoni, M., primary, Nisi, P., additional, Iaria, M., additional, Luzietti, E., additional, Sianesi, M., additional, and Viani, L., additional
- Published
- 2014
- Full Text
- View/download PDF
33. Percutaneous Ultrasound-Guided Radiofrequency Ablation of an Allograft Renal Cell Carcinoma: A Case Report
- Author
-
Olivani, A., primary, Iaria, M., additional, Missale, G., additional, Capocasale, E., additional, Biasini, E., additional, Mazzoni, M.P., additional, Lombardelli, L., additional, Luzi, E., additional, Frattini, A., additional, and Pelosi, G., additional
- Published
- 2011
- Full Text
- View/download PDF
34. Embolization of Pancreatic Allograft Arteriovenous Fistula with the Amplatzer Vascular Plug 4: Case Report and Literature Analysis
- Author
-
Buttarelli, L., primary, Capocasale, E., additional, Marcato, C., additional, Mazzoni, M.P., additional, Iaria, M., additional, and Rossi, C., additional
- Published
- 2011
- Full Text
- View/download PDF
35. Epidemiology and outcome of multiple trauma in the elderly population in a tertiary care hospital in southern Italy
- Author
-
Iaria, M, primary, Surleti, S, additional, Famá, F, additional, Villari, SA, additional, and Gioffré-Florio, M, additional
- Published
- 2009
- Full Text
- View/download PDF
36. Basiliximab Induction in Adult Liver Transplant Recipients With 93% Rejection-Free Patient and Graft Survival at 24 Months
- Author
-
Ramirez, C.B., primary, Doria, C., additional, DiFrancesco, F., additional, Iaria, M., additional, Kang, Y., additional, and Marino, I.R., additional
- Published
- 2006
- Full Text
- View/download PDF
37. c-Kit–Positive Mast Cells in Portal Tracts Cannot Be Used to Distinguish Acute Cellular Rejection From Recurrent Hepatitis C Infection in Liver Allografts
- Author
-
Doria, C., primary, di Francesco, F., additional, Marino, I.R., additional, Ramirez, C.B., additional, Frank, A., additional, Iaria, M., additional, Galati, S.A., additional, and Farber, J.L., additional
- Published
- 2006
- Full Text
- View/download PDF
38. The Presence of B-Cell Nodules Does Not Necessarily Portend a Less Favorable Outcome to Therapy in Patients With Acute Cellular Rejection of a Renal Allograft
- Author
-
Doria, C., primary, di Francesco, F., additional, Ramirez, C.B., additional, Frank, A., additional, Iaria, M., additional, Francos, G., additional, Marino, I.R., additional, and Farber, J.L., additional
- Published
- 2006
- Full Text
- View/download PDF
39. Cistoadenoma biliar con estroma mesenquimal "ovarian like" y niveles elevados de CA19.9
- Author
-
Ramírez Plaza, C. P., primary, Ruiz López, M., additional, Santoyo Santoyo, J., additional, Iaria, M., additional, Suárez Muñoz, M. A., additional, Jiménez Hernández, M., additional, Pérez Daga, J. A., additional, Fernández Aguilar, J. L., additional, Bondía Navarro, J. A., additional, and Fuente Perucho, A. de la, additional
- Published
- 2004
- Full Text
- View/download PDF
40. Chylous Ascites Following Laparoscopic Living Donor Nephrectomy
- Author
-
Iaria, M., Capocasale, E., FABIO VISTOLI, Signori, S., D Imporzano, S., Mazzoni, M. P., Dalla Valle, R., and Boggi, U.
41. The immunomodulatory molecule pidotimod induces the expression of the NOD-like receptor NLRP12 and attenuates TLR-induced inflammation
- Author
-
Fogli, M., Caccuri, F., Iaria, M. L., Giagulli, C., Corbellini, S., Campilongo, F., Caruso, A., and SIMONA FIORENTINI
- Subjects
Inflammation ,Toll-Like Receptors ,Intracellular Signaling Peptides and Proteins ,Humans ,Immunologic Factors ,Thiazolidines ,RNA, Messenger ,Chemokine CCL2 ,Pyrrolidonecarboxylic Acid - Abstract
Pidotimod (3-L-pyroglutamyl-L-thiaziolidine-4-carboxylic acid) (PDT) is a synthetic dipeptide with in vitro and in vivo immunomodulatory properties that is largely used for treatment and prevention of infections in paediatric and disease-prone patients. However, the effects of PDT on cellular immune responses are still poorly characterized and there is little information on the mechanism of action of this compound. It has been speculated that PDT action may be exerted through the interaction with a Pattern Recognition Receptor (PRR). Therefore, to gain a further understanding of the immune pathways involved by PDT, we first decided to investigate whether PDT could modify the immune response triggered by TLR ligands. Monocytic cells were exposed to PDT then stimulated with a panel of TLR agonists. Under these experimental conditions, we observed a significant decrease in the synthesis of key proinflammatory mediators in comparison to the production observed in TLR-stimulated cells that were not treated with PDT. Using RT² Profiler PCR Array we have observed that PDT specifically up-regulates the expression of the NOD-like receptor NLRP12 mRNA in the absence of any further costimulation. Increase of NLRP12 in cells treated with PDT was confirmed using specifically designed real-time quantitative PCR and western blotting assays where a clear increase in the amount of NLRP12 protein was detected. Furthermore, in myeloid/monocytic cells we demonstrated that PDT treatment counteracts the NLRP12 reduction induced by TLR agonists. Finally, the results obtained using NLRP12 silenced cells showed that down-regulation of the proinflammatory function occurring in PDT-treated cells upon interaction with TLRs is associated with the increased levels of NLRP12 induced by PDT. To our knowledge this is the first evidence of an immunomodulatory peptide that upregulates NLRP12 and, through this molecule, antagonizes the TLR-induced inflammatory response. These results pave the way for the development of innovative therapeutic approaches aimed at controlling different pathological settings such as tumorigenesis, systemic inflammatory processes and autoimmunity, where NLRP12 plays a crucial role.
42. Surgical overview on kidney and pancreas transplantation,Problemi chirurgici nel trapianto di rene e di pancreas - Position paper
- Author
-
Capocasale, E., Berardinelli, L., Beretta, C., Berloco, P., Boggi, U., Boschiero, L., Bretto, P., Carmellini, M., Citterio, F., Concone, G., Carlis, L., Rosa, P., Del Gaudio, M., Di Sandro, S., Di Tonno, P., Faenza, A., Famulari, A., Giacomoni, A., Giovannoni, M., Iaria, M., Lauterio, A., Lasaponara, F., Mazzoni, M. P., Nicita, G., Orsenigo, E., Parolini, D. C., Pietrabissa, A., Pinna, A. D., Pisani, F., Matteo Ravaioli, Rigotti, P., Romagnoli, J., Rossetti, O., Secchi, A., Socci, C., and Vistoli, F.
43. For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features
- Author
-
Fogli M, Iaria M, Focá E, Giagulli C, Francesca Caccuri, Maggi F, Torti C, Caruso A, and Fiorentini S
- Subjects
Adult ,Male ,Anti-HIV Agents ,CD4-CD8 Ratio ,Antiretroviral Therapy ,HIV Infections ,Middle Aged ,Highly Active ,Biomarkers ,Female ,HIV-1 ,Humans ,Lymphocyte Count ,Young Adult ,Antiretroviral Therapy, Highly Active - Abstract
There is disagreement on the optimal timing of HAART initiation based on absolute CD4+ T-cell count (CD4+ count). We investigated if na�ve patients with CD4+ T-cell percentage (%CD4+)29% or CD4+/CD8+ ratio1 display signs of immune deterioration notwithstanding CD4+ count ?500 cells/?l. We found that these patients show B-cell aberrations and an impaired control of Torque Teno Virus replication. By contrast, patients with CD4+?500/?l, %CD4+?29% and CD4+/CD8+?1 displayed features of healthy subjects. Results obtained suggest that a combination of these parameters could be an adequate surrogate marker of immunological competence. This will be helpful in deciding when to start HAART.
44. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC
- Author
-
Paola Tarchi, Pasquale Perri, Gian Luca Grazi, Marcello Maestri, Maurizio Romano, Giorgio Ercolani, Gian Luca Baiocchi, Michele Crespi, Federica Cipriani, Luca Fumagalli, Guido Torzilli, Matteo Donadon, Cecilia Ferrari, Paola Germani, Ivano Sciannamea, Raffaele Dalla Valle, Antonio Floridi, Sarah Molfino, A. Frena, Ivan Marchitelli, Francesco Ardito, Simone Famularo, Elio Jovine, Fabrizio Romano, Andrea Ruzzenente, G. Griseri, Luca Ansaloni, Antonella Delvecchio, Simone Conci, Giuliano La Barba, Giacomo Zanus, A. Antonucci, M. Iaria, Marco Chiarelli, Luca Aldrighetti, Enrico Pinotti, Stefan Patauner, Matteo Zanello, Riccardo Memeo, Mauro Zago, Felice Giuliante, Alberto Manzoni, Giuseppe Zimmitti, Albert Troci, Conci, S., Cipriani, F., Donadon, M., Marchitelli, I., Ardito, F., Famularo, S., Perri, P., Iaria, M., Ansaloni, L., Zanello, M., La Barba, G., Patauner, S., Pinotti, E., Molfino, S., Germani, P., Romano, M., Sciannamea, I., Ferrari, C., Manzoni, A., Troci, A., Fumagalli, L., Delvecchio, A., Floridi, A., Memeo, R., Chiarelli, M., Crespi, M., Zimmitti, G., Griseri, G., Antonucci, A., Zanus, G., Tarchi, P., Baiocchi, G. L., Zago, M., Frena, A., Ercolani, G., Jovine, E., Maestri, M., Valle, R. D., Grazi, G. L., Romano, F., Giuliante, F., Torzilli, G., Aldrighetti, L., Ruzzenente, A., Conci S., Cipriani F., Donadon M., Marchitelli I., Ardito F., Famularo S., Perri P., Iaria M., Ansaloni L., Zanello M., La Barba G., Patauner S., Pinotti E., Molfino S., Germani P., Romano M., Sciannamea I., Ferrari C., Manzoni A., Troci A., Fumagalli L., Delvecchio A., Floridi A., Memeo R., Chiarelli M., Crespi M., Zimmitti G., Griseri G., Antonucci A., Zanus G., Tarchi P., Baiocchi G.L., Zago M., Frena A., Ercolani G., Jovine E., Maestri M., Valle R.D., Grazi G.L., Romano F., Giuliante F., Torzilli G., Aldrighetti L., and Ruzzenente A.
- Subjects
Liver Cirrhosis ,Male ,Hepatocellular carcinoma ,Settore MED/18 - CHIRURGIA GENERALE ,medicine.medical_treatment ,Disease ,Comorbidity ,Gastroenterology ,Body Mass Index ,Neoplasms, Multiple Primary ,Non-alcoholic Fatty Liver Disease ,Multiple Primary ,Neoplasms ,Chronic ,Liver resection ,Liver Diseases ,Fatty liver ,Liver Neoplasms ,General Medicine ,Middle Aged ,Hepatitis B ,Alcoholic ,Metabolic syndrome ,Hepatitis C ,Tumor Burden ,Survival Rate ,Oncology ,Metabolic associated fatty liver disease ,Population study ,Female ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Disease-Free Survival ,NO ,Hepatitis B, Chronic ,Hepatectomy ,NAFLD ,Internal medicine ,medicine ,Humans ,Propensity Score ,neoplasms ,Pathological ,Liver Diseases, Alcoholic ,Aged ,business.industry ,Carcinoma ,Hepatocellular ,Hepatitis C, Chronic ,medicine.disease ,digestive system diseases ,Propensity score matching ,Surgery ,business - Abstract
Background and aims: We investigated the clinical impact of the newly defined metabolic-associated fatty liver disease (MAFLD) in patients undergoing hepatectomy for HCC (MAFLD-HCC) comparing the characteristics and outcomes of patients with MAFLD-HCC to viral- and alcoholic-related HCC (HCV-HCC, HBV-HCC, A-HCC). Methods: A retrospective analysis of patients included in the He.RC.O.Le.S. Group registry was performed. The characteristics, short- and long-term outcomes of 1315 patients included were compared according to the study group before and after an exact propensity score match (PSM). Results: Among the whole study population, 264 (20.1%) had MAFLD-HCC, 205 (15.6%) had HBV-HCC, 671 (51.0%) had HCV-HCC and 175 (13.3%) had A-HCC. MAFLD-HCC patients had higher BMI (p < 0.001), Charlson Comorbidities Index (p < 0.001), size of tumour (p < 0.001), and presence of cirrhosis (p < 0.001). After PSM, the 90-day mortality and severe morbidity rates were 5.9% and 7.1% in MAFLD-HCC, 2.3% and 7.1% in HBV-HCC, 3.5% and 11.7% in HCV-HCC, and 1.2% and 8.2% in A-HCC (p = 0.061 and p = 0.447, respectively). The 5-year OS and RFS rates were 54.4% and 37.1% in MAFLD-HCC, 64.9% and 32.2% in HBV-HCC, 53.4% and 24.7% in HCV-HCC and 62.0% and 37.8% in A-HCC (p = 0.345 and p = 0.389, respectively). Cirrhosis, multiple tumours, size and satellitosis seems to be the independent predictors of OS. Conclusion: Hepatectomy for MAFLD-HCC seems to have a higher but acceptable operative risk. However, long-term outcomes seems to be related to clinical and pathological factors rather than aetiological risk factors.
- Published
- 2022
45. Risk-adjusted benchmarks in laparoscopic liver surgery in a national cohort
- Author
-
Nadia Russolillo, L. Vincenti, M. Iaria, R. Lo Tesoriere, Giulio Belli, R. Dalla Valle, Enrico Gringeri, Alberto Brolese, Roberto Santambrogio, Luca Aldrighetti, F. Di Benedetto, Fausto Zamboni, L. De Carlis, Giuseppe Zimmitti, Felice Giuliante, Vincenzo Mazzaferro, Elio Jovine, Graziano Ceccarelli, G.B. Levi Sandri, Alfredo Guglielmi, Fabio Ferla, P. Mezzatesta, Matteo Virdis, S. Berti, Fulvio Calise, Giuseppe Navarra, Salvatore Gruttadauria, Annamaria Ferrero, Francesco Ardito, Umberto Cillo, E. Rossi, A. Coratti, R. Lombardi, Francesca Ratti, Guido Torzilli, Ugo Boggi, Matteo Ravaioli, Andrea Ruzzenente, Giuseppe Maria Ettorre, Russolillo, N, Aldrighetti, L, Cillo, U, Guglielmi, A, Ettorre, G, Giuliante, F, Mazzaferro, V, Dalla Valle, R, De Carlis, L, Jovine, E, Ferrero, A, Russolillo N., Aldrighetti L., Cillo U., Guglielmi A., Ettorre G.M., Giuliante F., Mazzaferro V., Dalla Valle R., De Carlis L., Jovine E., Ferrero A., Ratti F., Lo Tesoriere R., Gringeri E., Ruzzenente A., Levi Sandri G.B., Ardito F., Virdis M., Iaria M., Ferla F., Lombardi R., Di Benedetto F., Gruttadauria S., Boggi U., Torzilli G., Rossi E., Vincenti L., Berti S., Ceccarelli G., Belli G., Zamboni F., Calise F., Coratti A., Santambrogio R., Brolese A., Navarra G., Mezzatesta P., Zimmitti G., Ravaioli M., Russolillo, N., Aldrighetti, L., Cillo, U., Guglielmi, A., Ettorre, G. M., Giuliante, F., Mazzaferro, V., Dalla Valle, R., De Carlis, L., Jovine, E., Ferrero, A., Ratti, F., Lo Tesoriere, R., Gringeri, E., Ruzzenente, A., Levi Sandri, G. B., Ardito, F., Virdis, M., Iaria, M., Ferla, F., Lombardi, R., Di Benedetto, F., Gruttadauria, S., Boggi, U., Torzilli, G., Rossi, E., Vincenti, L., Berti, S., Ceccarelli, G., Belli, G., Zamboni, F., Calise, F., Coratti, A., Santambrogio, R., Brolese, A., Navarra, G., Mezzatesta, P., Zimmitti, G., and Ravaioli, M.
- Subjects
Liver surgery ,Male ,ACHIEVABLE BENCHMARKS ,Cirrhosis ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,ESTABLISHING BENCHMARKS ,CARE ,COMPLICATIONS ,PROPOSAL ,030230 surgery ,0302 clinical medicine ,Postoperative Complications ,Risk Factors ,benchmarks ,Registries ,Laparoscopy ,liver surgery ,medicine.diagnostic_test ,Bowel resection ,Benchmarking ,Treatment Outcome ,Italy ,liver resection ,030211 gastroenterology & hepatology ,Female ,medicine.medical_specialty ,National cohort ,Coronavirus, SARS-CoV-2COVID-19Pandemic, Obesity, Bariatric surgery ,03 medical and health sciences ,Internal medicine ,medicine ,Hepatectomy ,Humans ,Obesity ,Quality of Health Care ,Bariatric surgery ,major morbidity ,business.industry ,Minimally Invasive Liver Surgery ,laparoscopic liver surgery ,Odds ratio ,Risk adjustment ,medicine.disease ,Coronavirus ,benchmarks, laparoscopic ,SARS-CoV-2COVID-19Pandemic ,Surgery ,business - Abstract
This study aimed to assess the best achievable outcomes in laparoscopic liver resection (LLR) after risk adjustment based on surgical technical difficulty using a national registry.LLRs registered in the Italian Group of Minimally Invasive Liver Surgery registry from November 2014 to March 2018 were considered. Benchmarks were calculated according to the Achievable Benchmark of Care (ABC™). LLRs at each centre were divided into three clusters (groups I, II and III) based on the Kawaguchi classification. ABCs for overall and major morbidity were calculated in each cluster. Multivariable analysis was used to identify independent risk factors for overall and major morbidity. Significant variables were used in further risk adjustment.A total of 1752 of 2263 patients fulfilled the inclusion criteria: 1096 (62·6 per cent) in group I, 435 (24·8 per cent) in group II and 221 (12·6 per cent) in group III. The ABCs for overall morbidity (7·8, 14·2 and 26·4 per cent for grades I, II and II respectively) and major morbidity (1·4, 2·2 and 5·7 per cent) increased with the difficulty of LLR. Multivariable analysis showed an increased risk of overall morbidity associated with multiple LLRs (odds ratio (OR) 1·35), simultaneous intestinal resection (OR 3·76) and cirrhosis (OR 1·83), and an increased risk of major morbidity with intestinal resection (OR 4·61). ABCs for overall and major morbidity were 14·4 and 3·2 per cent respectively for multiple LLRs, 30 and 11·1 per cent for intestinal resection, and 14·9 and 4·8 per cent for cirrhosis.Overall morbidity benchmarks for LLR ranged from 7·8 to 26·4 per cent, and those for major morbidity from 1·4 to 5·7 per cent, depending on complexity. Benchmark values should be adjusted according to multiple LLRs or simultaneous intestinal resection and cirrhosis.Este estudio tuvo como objetivo evaluar los mejores resultados que se pueden conseguir en la resección hepática laparoscópica (laparoscopic liver resection, LLR) después del ajuste por riesgos basado en la dificultad de la técnica quirúrgica utilizando un registro nacional. MÉTODOS: Se consideraron las LLRs incluidas en el Registro del Grupo Italiano de Cirugía Hepática Mínimamente Invasiva desde 11/2014 a 03/2018. Los resultados de referencia (benchmarks) se calcularon de acuerdo con el Achievable Benchmark of Care (ABC™). Las LLRs de cada uno de los centros se dividieron en 3 grupos (Grupo I, II y III) en base a la clasificación de Kawaguchi. Se calculó el ABC de la morbilidad global y de la morbilidad mayor para cada grupo. Se realizó un análisis multivariable para identificar los factores independientes de riesgos para la morbilidad global y morbilidad mayor. Se utilizaron variables significativas para realizar ajustes de riesgo adicionales.Un total de 1.752 pacientes de los 2.263 cumplían los criterios de inclusión, de los cuales 1.096 (62,6%) se incluyeron en el Grupo I, 435 (24,8%) en el Grupo II y 221 (12,6%) en el Grupo III. El ABC de la morbilidad global (7,8%, 14,2%, 26,4%) y de la morbilidad mayor (1,4%, 2,2%, 5,7%) aumentó del Grupo I al Grupo III. El análisis multivariable mostró un incremento del riesgo para la morbilidad global asociada con múltiples LLRs (razón de oportunidades, odds ratio, OR 1,349), resección intestinal simultánea (OR 3,760) y cirrosis (OR 1,825), y para la morbilidad mayor con la resección intestinal (OR 4,606). Los ABC de la morbilidad global y morbilidad mayor fueron 14,4% y 3,2% para las LLR múltiples, 30% y 11% para la resección intestinal, y 14,9% y 4,8% para la cirrosis, respectivamente. CONCLUSIÓN: Los resultados de referencia (benchmark) para la morbilidad global y morbilidad mayor en la LLR variaron entre un 8% y un 26% y entre un 1,4% y un 5,7%, dependiendo de la complejidad. Los valores de referencia deberían ajustarse de acuerdo con la práctica de LLRs múltiples o resección intestinal simultánea y cirrosis.
- Published
- 2020
46. Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry
- Author
-
G.L. Grazi, Fausto Zamboni, Fulvio Calise, Giovanni Sgroi, Giorgio Rossi, Antonio Giuliani, G.B. Levi Sandri, S. Berti, Abdallah Slim, Antonio Floridi, Roberto Santambrogio, P. Mezzatesta, Felice Giuliante, Giulio Belli, Giovanni Vennarecci, Salvatore Gruttadauria, Vincenzo Mazzaferro, R. Dalla Valle, Alberto Brolese, Alessandro Ferrero, A. Coratti, Francesca Ratti, Nadia Russolillo, Andrea Ruzzenente, Giuseppe Maria Ettorre, A. Antonucci, Giuseppe Navarra, M. Iaria, L. Vincenti, P. Bonsignore, P. Maida, Ugo Boggi, G. Griseri, A. Parisi, Alfredo Guglielmi, Elio Jovine, Enrico Gringeri, Guido Torzilli, Umberto Cillo, Michele Colledan, F. Di Benedetto, Paolo Magistri, A. Frena, Fabio Ferla, Andrea Scotti, Matteo Virdis, A.D. Pinna, Luca Aldrighetti, L. De Carlis, Graziano Ceccarelli, Sandri, Gbl, Ettorre, Gm, Aldrighetti, L, Cillo, U, Dalla Valle, R, Guglielmi, A, Mazzaferro, V, Ferrero, A, Di Benedetto, F, Gruttadauria, S, De Carlis, L, Vennarecci, G, Antonucci, A, Belli, G, Berti, S, Boggi, U, Bonsignore, P, Brolese, A, Calise, F, Ceccarelli, G, Colledan, M, Coratti, A, Ferla, F, Floridi, A, Frena, A, Giuliani, A, Giuliante, F, Grazi, Gl, Gringeri, E, Griseri, G, Iaria, M, Jovine, E, Paolo, M, Maida, P, Mezzatesta, P, Russolillo, N, Navarra, G, Parisi, A, Pinna, Ad, Ratti, F, Rossi, Ge, Ruzzenente, A, Santambrogio, R, Scotti, A, Sgroi, G, Slim, A, Torzilli, G, Vincenti, L, Virdis, M, Zamboni, F, Levi Sandri G.B., Ettorre G.M., Aldrighetti L., Cillo U., Dalla Valle R., Guglielmi A., Mazzaferro V., Ferrero A., Di Benedetto F., Gruttadauria S., De Carlis L., Vennarecci G., Antonucci A., Belli G., Berti S., Boggi U., Bonsignore P., Brolese A., Calise F., Ceccarelli G., Colledan M., Coratti A., Ferla F., Floridi A., Frena A., Giuliani A., Giuliante F., Grazi G.L., Gringeri E., Griseri G., Iaria M., Jovine E., Magistri P., Maida P., Mezzatesta P., Russolillo N., Navarra G., Parisi A., Pinna A.D., Ratti F., Rossi G.E., Ruzzenente A., Santambrogio R., Scotti A., Sgroi G., Slim A., Torzilli G., Vincenti L., Virdis M., Zamboni F., Levi Sandri, G, Ettorre, G, Grazi, G, Magistri, P, Pinna, A, and Rossi, G
- Subjects
Laparoscopic surgery ,Registrie ,Male ,Hepatocellular carcinoma ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,Laparoscopic HCC, Posterior segment, Hepatocellular carcinoma, IGoMILS, Child B, Laparoscopic liver resection ,0302 clinical medicine ,Postoperative Complications ,Prospective Studies ,Registries ,Laparoscopy ,Prospective cohort study ,medicine.diagnostic_test ,Laparoscopic HCC ,Liver Neoplasms ,Margins of Excision ,IGoMILS ,Middle Aged ,Laparoscopic liver resection ,Child B ,Italy ,Liver Neoplasm ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Female ,Human ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Matched-Pair Analysis ,Operative Time ,NO ,03 medical and health sciences ,medicine ,Humans ,Hepatectomy ,Blood Transfusion ,Matched-Pair Analysi ,Posterior segment ,Aged ,Postoperative Care ,LS7_4 ,Surgery ,business.industry ,Carcinoma ,Hepatocellular ,Perioperative ,medicine.disease ,digestive system diseases ,Child B, Hepatocellular carcinoma, IGoMILS, Laparoscopic HCC, Laparoscopic liver resection, Posterior segment, Aged, Blood Transfusion, Carcinoma, Hepatocellular, Female, Humans, Italy, Liver Neoplasms, Male, Margins of Excision, Matched-Pair Analysis, Middle Aged, Operative Time, Postoperative Care, Postoperative Complications, Prospective Studies, Registries, Hepatectomy, Laparoscopy ,Prospective Studie ,Propensity score matching ,Postoperative Complication ,business ,Abdominal surgery - Abstract
Objective: Laparoscopic liver resection (LLR) for Hepatocellular Carcinoma (HCC) is one of the most important indications for the minimally invasive approach. Our study aims to analyze the experience of the Italian Group of Minimally Invasive Liver Surgery with laparoscopic surgical treatment of HCC, with a focus on tumor location and how it affects morbidity and mortality. Methods: 38 centers participated in this study; 372 cases of LLR for HCC were prospectively enrolled. Patients were divided into two groups according to the HCC nodule location. Group 1 favorable location and group 2 unfavorable location. Perioperative outcomes were compared between the two groups before and after a propensity score match (PS) 1:1. Results: Before PS in group 2 surgical time was longer; conversion rate was higher; postoperative transfusion and comprehensive complication index were also higher. PS was performed with a cohort of 298 patients (from 18 centers), with 66 and 232 patients with HCC in unfavorable and favorable locations, respectively. After PS matching, 62 patients from group 1 and group 2 each were compared. Operative and postoperative course were similar in patients with HCC in favorable and unfavorable LLR locations. Surgical margins were found to be identical before and after PS. Conclusions: These results show that LLR in patients with HCC can be safely performed in all segments because of the extensive experience of all surgeons from multiple centers in performing traditional open liver surgery as well as laparoscopic surgery.
- Published
- 2019
47. [Surgical overview on kidney and pancreas transplantation]
- Author
-
Capocasale, Enzo, Berardinelli, Luisa, Beretta, Claudio, Berloco, Pasquale, UGO BOGGI, Boschiero, Luigino, Bretto, Piero, Carmellini, Mario, Citterio, Franco, Concone, Giacomo, Carlis, Luciano, Rosa, Paride, Del Gaudio, Massimo, Di Sandro, Stefano, Di Tonno, Pasquale, Faenza, Alessandro, Famulari, Antonio, Giacomoni, Alessandro, Giovannoni, Massimo, Iaria, Maurizio, Lauterio, Andrea, Lasaponara, Fedele, Mazzoni, Maria Patrizia, Nicita, Giulio, Orsenigo, Elena, Parolini, Danilo Carlo, Pietrabissa, Andrea, Pinna, Antonio Daniele, Pisani, Franco, Ravaioli, Matteo, Rigotti, Paolo, Romagnoli, Jacopo, Rossetti, Ornella, Secchi, Antonio, Socci, Carlo, FABIO VISTOLI, Capocasale, E., Berardinelli, L., Beretta, C., Berloco, P., Boggi, U., Boschiero, L., Bretto, P., Carmellini, M., Citterio, F., Concone, G., De Carlis, L., De Rosa, P., Del Gaudio, M., Di Sandro, S., Di Tonno, P., Faenza, A., Famulari, A., Giacomoni, A., Giovannoni, M., Iaria, M., Lauterio, A., Lasaponara, F., Mazzoni, M. P., Nicita, G., Orsenigo, E., Parolini, D. C., Pietrabissa, A., Pinna, A. D., Pisani, F., Ravaioli, M., Rigotti, P., Romagnoli, J., Rossetti, O., Secchi, A., Socci, C., Vistoli, F., Capocasale, E, Berardinelli, L, Beretta, C, Berloco, P, Boggi, U, Boschiero, L, Bretto, P, Carmellini, M, Citterio, F, Concone, G, De Carlis, L, De Rosa, P, Del Gaudio, M, Di Sandro, S, Di Tonno, P, Faenza, A, Famulari, A, Giacomoni, A, Giovannoni, M, Iaria, M, Lauterio, A, Lasaponara, F, Mazzoni, M, Nicita, G, Orsenigo, E, Parolini, D, Pietrabissa, A, Pinna, A, Pisani, F, Ravaioli, M, Rigotti, P, Romagnoli, J, Rossetti, O, Secchi, A, Socci, C, and Vistoli, F
- Subjects
Settore MED/18 - CHIRURGIA GENERALE ,Medicine (all) ,Patient Selection ,Pancreatic Diseases ,Humans ,Kidney Diseases ,Nephrectomy ,Pancreatectomy ,Perioperative Care ,Postoperative Complications ,Practice Guidelines as Topic ,Tissue and Organ Harvesting ,Kidney Transplantation ,Pancreas Transplantation - Abstract
The main purpose of this paper, written by a group of Italian expert transplant surgeons, is to provide clinical support and to help through the decision-making process over pre-transplant surgical procedures in potential kidney recipients, as well as selection of pancreas transplant candidates and perioperative management of kidney recipient. Current topics such as different approaches in minimally invasive donor nephrectomy, methods of graft preservation and treatment of failed allograft were addressed.
- Published
- 2016
48. The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients
- Author
-
Franco Citterio, Pierluca Piselli, Ghil Busnach, Claudia Cimaglia, Andrea Ambrosini, Luigi Biancone, Martina Taborelli, Diego Serraino, Maria Rosaria Campise, Giuseppe Tisone, Lucrezia Furian, Paola Todeschini, Nicola Bossini, Francesco Pisani, Maurizio Iaria, Massimiliano Veroux, Margherita Mangino, Flavia Caputo, Vincenzo Cantaluppi, Davide Argiolas, Marco Fiorentino, Taborelli M., Serraino D., Cimaglia C., Furian L., Biancone L., Busnach G., Todeschini P., Bossini N., Iaria M., Campise M.R., Veroux M., Citterio F., Ambrosini A., Cantaluppi V., Mangino M., Pisani F., Tisone G., Fiorentino M., Argiolas D., Caputo F., and Piselli P.
- Subjects
Nephrology ,Graft Rejection ,medicine.medical_specialty ,nephrology ,Malignancy ,Cohort Studies ,Risk Factors ,Internal medicine ,Neoplasms ,Epidemiology ,medicine ,Immunology and Allergy ,cancer ,Humans ,Pharmacology (medical) ,Index case ,Kidney transplantation ,science ,Transplantation ,business.industry ,Hazard ratio ,Graft Survival ,Cancer ,medicine.disease ,Kidney Transplantation ,Transplant Recipients ,Settore MED/18 ,neoplasia ,translational research ,Cohort ,Kidney Failure, Chronic ,epidemiology ,business ,kidney transplantation ,malignancy - Abstract
This study assessed the impact of cancer on the risk of death with a functioning graft of kidney transplant (KT) recipients, as compared to corresponding recipients without cancer. A matched cohort study was conducted using data from a cohort of 13245 individuals who had undergone KT in 17 Italian centers (1997–2017). Cases were defined as subjects diagnosed with any cancer after KT. For each case, two controls matched by gender, age, and year at KT were randomly selected from cohort members who were cancer-free at the time of diagnosis of the index case. Overall, 292 (20.5%) deaths with a functioning graft were recorded among 1425 cases and 238 (8.4%) among 2850 controls. KT recipients with cancer had a greater risk of death with a functioning graft (hazard ratio, HR=3.31) than their respective controls. This pattern was consistent over a broad range of cancer types, including non-Hodgkin lymphoma (HR=33.09), lung (HR=20.51), breast (HR=8.80), colon-rectum (HR=3.51), and kidney (HR=2.38). The survival gap was observed throughout the entire follow-up period, though the effect was more marked within 1year from cancer diagnosis. These results call for close posttransplant surveillance to detect cancers at earlier stages when treatments are more effective in improving survival.
- Published
- 2021
49. Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison
- Author
-
Simone Famularo, Matteo Donadon, Federica Cipriani, Davide P. Bernasconi, Giuliano LaBarba, Tommaso Dominioni, Maurizio Iaria, Sarah Molfino, Simone Conci, Cecilia Ferrari, Marco Garatti, Antonella Delvecchio, Albert Troci, Stefan Patauner, Silvia Frassani, Maurizio Cosimelli, Giacomo Zanus, Felice Giuliante, Elio Jovine, Maria G. Valsecchi, GianLuca Grazi, Adelmo Antonucci, Antonio Frena, Michele Crespi, Riccardo Memeo, Giuseppe Zimmitti, Guido Griseri, Andrea Ruzzenente, Gianluca Baiocchi, Raffaele DallaValle, Marcello Maestri, Giorgio Ercolani, Luca Aldrighetti, Guido Torzilli, Fabrizio Romano, Cristina Ciulli, Alessandro Giani, Francesca Carissimi, Guido Costa, Francesca Ratti, Alessandro Cucchetti, Francesco Calabrese, Elena Cremaschi, Giovanni Lazzari, Angelo Franceschi, Valentina Sega, Maria Conticchio, Luca Pennacchi, Michele Ciola, Ivano Sciannamea, Valerio De Peppo, Famularo S., Donadon M., Cipriani F., Bernasconi D.P., LaBarba G., Dominioni T., Iaria M., Molfino S., Conci S., Ferrari C., Garatti M., Delvecchio A., Troci A., Patauner S., Frassani S., Cosimelli M., Zanus G., Giuliante F., Jovine E., Valsecchi M.G., Grazi G., Antonucci A., Frena A., Crespi M., Memeo R., Zimmitti G., Griseri G., Ruzzenente A., Baiocchi G., DallaValle R., Maestri M., Ercolani G., Aldrighetti L., Torzilli G., Romano F., Ciulli C., Giani A., Carissimi F., Costa G., Ratti F., Cucchetti A., Calabrese F., Cremaschi E., Lazzari G., Franceschi A., Sega V., Conticchio M., Pennacchi L., Ciola M., Sciannamea I., De Peppo V., Famularo, Simone, Donadon, Matteo, Cipriani, Federica, Bernasconi, Davide P, Labarba, Giuliano, Dominioni, Tommaso, Iaria, Maurizio, Molfino, Sarah, Conci, Simone, Ferrari, Cecilia, Garatti, Marco, Delvecchio, Antonella, Troci, Albert, Patauner, Stefan, Frassani, Silvia, Cosimelli, Maurizio, Zanus, Giacomo, Giuliante, Felice, Jovine, Elio, Valsecchi, Maria G, Grazi, Gianluca, Antonucci, Adelmo, Frena, Antonio, Crespi, Michele, Memeo, Riccardo, Zimmitti, Giuseppe, Griseri, Guido, Ruzzenente, Andrea, Baiocchi, Gianluca, Dallavalle, Raffaele, Maestri, Marcello, Ercolani, Giorgio, Aldrighetti, Luca, Torzilli, Guido, and Romano, Fabrizio
- Subjects
Sorafenib ,medicine.medical_specialty ,recurrence ,Carcinoma, Hepatocellular ,Tumor burden ,030230 surgery ,liver ,Gastroenterology ,NO ,03 medical and health sciences ,0302 clinical medicine ,hepatectomy ,Retrospective Studie ,Internal medicine ,Humans ,Medicine ,Chemoembolization, Therapeutic ,Liver surgery ,Retrospective Studies ,LS7_4 ,Hepatology ,business.industry ,Palliative Care ,Liver Neoplasms ,hepatocellular carcinoma ,medicine.disease ,Recurrent Hepatocellular Carcinoma ,multicentric ,Treatment Outcome ,Time to recurrence ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Liver function ,Neoplasm Recurrence, Local ,business ,medicine.drug ,Human - Abstract
Background Management of recurrence after surgery for hepatocellular carcinoma (rHCC) is still a debate. The aim was to compare the Survival after Recurrence (SAR) of curative (surgery or thermoablation) versus palliative (TACE or Sorafenib) treatments for patients with rHCC. Methods This is a multicentric Italian study, which collected data between 2007 and 2018 from 16 centers. Selected patients were then divided according to treatment allocation in Curative (CUR) or Palliative (PAL) Group. Inverse Probability Weighting (IPW) was used to weight the groups. Results 1,560 patients were evaluated, of which 421 experienced recurrence and were then eligible: 156 in CUR group and 256 in PAL group. Tumor burden and liver function were weighted by IPW, and two pseudo-population were obtained (CUR = 397.5 and PAL = 415.38). SAR rates at 1, 3 and 5 years were respectively 98.3%, 76.7%, 63.8% for CUR and 91.7%, 64.2% and 48.9% for PAL (p = 0.007). Median DFS was 43 months (95%CI = 32-74) for CUR group, while it was 23 months (95%CI = 18-27) for PAL (p = 0.017). Being treated by palliative approach (HR = 1.75; 95%CI = 1.14–2.67; p = 0.01) and having a median size of the recurrent nodule>5 cm (HR = 1.875; 95%CI = 1.22–2.86; p = 0.004) were the only predictors of mortality after recurrence, while time to recurrence was the only protective factor (HR = 0.616; 95%CI = 0.54–0.69; p Conclusion Curative approaches may guarantee long-term survival in case of recurrence.
- Published
- 2021
50. Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy
- Author
-
Pasquale Ditonno, Mauro Frongia, A. Collini, Massimo Abelli, Salvatore Gruttadauria, Caterina Di Bella, Danilo Carlo Parolini, Elena Ticozzelli, Mario Carmellini, Gionata Spagnoletti, Flavia Caputo, Andrea Airoldi, Maria Paola Salerno, Vanessa De Pace, Barbara Buscemi, Umberto Baccarani, Enzo Capocasale, Alessandro Giacomoni, Nguefouet Momo Rostand, Andrea Solinas, Antenore Giussani, Gianmarco Bondonno, Gian Luigi Adani, Antonio Daniele Pinna, Maurizio Iaria, Andrea Bosio, Luciano De Carlis, Luigino Boschiero, Carlo Socci, Stefano Vittorio Impedovo, Giovanni Pasquale, Matteo Ravaioli, Claudio Beretta, Jacopo Romagnoli, Lucrezia Furian, Marco Spada, Ravaioli, M, Capocasale, E, Furian, L, De Pace, V, Iaria, M, Spagnoletti, G, Salerno, M, Giacomoni, A, De Carlis, L, Di Bella, C, Rostand, N, Boschiero, L, Pasquale, G, Bosio, A, Collini, A, Carmellini, M, Airoldi, A, Bondonno, G, Ditonno, P, Impedovo, S, Beretta, C, Giussani, A, Socci, C, Parolini, D, Abelli, M, Ticozzelli, E, Baccarani, U, Adani, G, Caputo, F, Buscemi, B, Frongia, M, Solinas, A, Gruttadauria, S, Spada, M, Pinna, A, and Romagnoli, J
- Subjects
Nephrology ,Male ,Time Factors ,volume transplant centre ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,030232 urology & nephrology ,mini-invasive surgical approach ,030230 surgery ,Kidney ,Nephrectomy ,delayed graft function ,donor outcome ,living donor transplant ,0302 clinical medicine ,Living Donors ,Medicine ,Laparoscopy ,Kidney transplantation ,medicine.diagnostic_test ,Graft Survival ,Middle Aged ,Hospitals ,medicine.anatomical_structure ,Tissue and Organ Harvesting ,Female ,Artery ,medicine.medical_specialty ,Hospitals, Low-Volume ,Donor Selection ,High-Volume ,03 medical and health sciences ,Internal medicine ,Low-Volume ,Humans ,Transplantation ,business.industry ,Donor selection ,Perioperative ,medicine.disease ,Kidney Transplantation ,Surgery ,Hospitals, High-Volume ,business - Abstract
Background Selection of the right or left living donor kidney for transplantation is influenced by many variables. In the present multi centric study including 21 Italian transplant centres, we evaluated whether centre volume or surgical technique may influence the selection process. Methods Intra- and perioperative donor data, donor kidney function, and recipient and graft survival were collected among 693 mini-invasive living donor nephrectomies performed from 2002 to 2014. Centre volume (LOW, 1-50 cases; HIGH, >50 cases) and surgical technique (FULL-LAP, full laparoscopic and robotic; HA-LAP, hand-assisted laparoscopy; MINI-OPEN, mini-lumbotomy) were correlated with selection of right or left donor kidney and with donor and recipient outcome. Results HIGH-volume centres retrieved a higher rate of donor right kidneys (29.3% versus 17.6%, P
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.